Dustin Blitchok

Dustin Blitchok

Benzinga Editor

About
Dustin Blitchok is senior editor and is proud to have been part of Benzinga's newsroom since 2017. His journalism career began at a daily newspaper, The Oakland Press, and has included investigative work and reporting on government, crime, courts, bu...
Delta Flight Returns To Atlanta After Takeoff: Boeing 757 'Yawing Aggressively'
Cannabis CEO To SEC Attorney: 'Eat S---'
EXCLUSIVE: Tommy Chong On Cheech And Chong's SXSW Premiere, Cannabis Legalization, The Perils Of Infused Popcorn
EXCLUSIVE: California Cannabis Investor Takes Page From Warren Buffett's Playbook — 'Trust Is Everything'
EXCLUSIVE: For Cannabis Companies, The Key To Growth In Ultra-Competitive Market Is 'Be Choosy'
Yellen Urges Focus On Long-Term Inflation Trend After January Data Rattles Markets: 'Inflation Is Moving Decisively Down'
Sports Illustrated Hit With Mass Layoffs After Missed Licensing Payment
Economic Data Takes Pressure Off Fed For Another Rate Hike, SEC Loses Court Fight Over Bitcoin ETF, Cannabis Stocks Rally With Drug's DEA Classification Under Review: The Week In The Markets
Russian Rockets Strike Poland, Killing 2: Report
Elon Musk Plans To Gut Twitter Workforce: Report
Detroit Auto Show Returns As Fall Event With EV Focus: What You Need To Know
An Orange Ray Of Light For Truth Social? Trump Says 'No' To Twitter Return Despite Musk News
EXCLUSIVE: How Isiah Thomas Is Making An ESG Play With Cannabis
EXCLUSIVE: Why This Billionaire Cannabis Exec Is Looking To Europe For Industry's Next Growth Stage
Feds Say Nope To Guns And Dope: Florida Agriculture Commissioner Says Medical Marijuana Cardholders Deprived Of Second Amendment Rights
EXCLUSIVE: Curaleaf's Boris Jordan On Next Steps To Legal Cannabis, Why 'We've Never Been Closer Than We Are Now'
EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
EXCLUSIVE: Kevin O'Leary On Why Cannabis Industry Attracts 'Zero' Institutional Dollars
EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge